A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/15161693

Clin. Cancer Res. 2004 May 15 10 10 3386-95

Download in:

View as

Triples

General Info

PMID
15161693